Alphatec Holdings, Inc.

Alphatec Holdings, Inc. is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. Its product portfolio includes the Alpha InformatiX platform featuring the EOS imaging system for full-body imaging, the SafeOp Neural InformatiX System for automated neuromonitoring, and the Valence intra-operative system that integrates navigation and robotics into spine procedures. Other offerings include the Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems, split-blade retractors, and the Sigma-ALIF Access System. The company also provides spinal implants and fixation systems such as NanoTec and Invictus, as well as biologics like 3D ProFuse Osteoconductive Bioscaffold, AlphaGRAFT Demineralized Bone Matrix (DBM), BioCORE Moldable Bioactive Graft, and Amnioshield Amniotic Tissue Barrier.

Alphatec Holdings, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol ATEC. The company trades in United States Dollars (USD). As a US-based company, its stock is denominated in USD, which is the standard currency for equities listed on US exchanges. Investors should be aware that currency fluctuations may affect returns for non-US investors, but the primary trading currency is USD.

Alphatec Holdings, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. This means the company is involved in the development, manufacturing, and sale of medical equipment and technologies used by healthcare professionals. In Alphatec's case, its focus is on surgical treatments for spinal disorders, offering a range of implants, instruments, imaging systems, and biologics. The Medical Devices industry is highly regulated and requires significant investment in research and development to bring innovative products to market. Alphatec's products are used by surgeons in hospitals and surgical centers to treat conditions such as degenerative disc disease, spinal deformities, and trauma.

Alphatec Holdings, Inc. is headquartered in the United States and serves both domestic and global markets. The company's description indicates that it operates in the United States and globally, meaning its products are available to surgeons and patients worldwide. While the specific headquarters location is not provided in the data, the company is based in the US and its stock is listed on the Nasdaq. Alphatec's global reach suggests it has distribution networks or direct sales operations in multiple countries, allowing it to compete in the international spinal surgery market.

Alphatec's portfolio includes several notable products and technologies for spinal surgery. The Alpha InformatiX platform features the EOS imaging system, which provides full-body imaging for precise diagnosis and planning. The SafeOp Neural InformatiX System automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring to protect neural structures during surgery. The Valence system integrates navigation and robotics into spine procedures, enhancing accuracy. For access, the Sigma Prone TransPsoas (PTP) Access System and PTP Patient Positioning Systems, along with split-blade retractors, facilitate minimally invasive approaches. The Sigma-ALIF Access System is designed for anterior lumbar interbody fusion. In terms of implants, the NanoTec and Invictus fixation systems offer stability, while standalone implants aid height restoration. Biologics include 3D ProFuse Osteoconductive Bioscaffold, AlphaGRAFT DBM in various forms, BioCORE Moldable Bioactive Graft, and Amnioshield Amniotic Tissue Barrier.